Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 17.583.14-40.091,061.31222.71

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 17.58 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31
Mar2020222.71

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31
376.54
Mar2020 222.71 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹398.2 Cr 0.9% -7.7% -19.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,271.0 Cr -0.9% -4.8% 50.2% Stock Analytics
DIVIS LABORATORIES ₹161,183.0 Cr 3% 5.9% 65% Stock Analytics
CIPLA ₹120,605.0 Cr 1.5% 0.1% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,869.0 Cr -0.4% -8.2% 7.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,808.6 Cr 0.6% -5.3% 51% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.9%

-7.7%

-19.9%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses